The Supreme Court is leaving in place a $2 billion verdict in favor of women who claim they developed ovarian cancer from using Johnson & Johnson talc products.
The justices did not comment Tuesday in rejecting Johnson & Johnson's appeal. The company argued that it was not treated fairly in facing one trial involving 22 cancer sufferers who came from 12 states and different backgrounds.
A Missouri jury initially awarded the women $4.7 billion, but a state appeals court dropped two women from the suit and reduced the award to $2 billion. The jury found that the company’s talc products contain asbestos and asbestos-laced talc can cause ovarian cancer. The company disputes both points.
Johnson & Johnson, which is based in New Brunswick, New Jersey, has stopped selling its iconic talc-based Johnson’s Baby Powder in the U.S. and Canada, though it remains on the market elsewhere.
Justices Samuel Alito and Brett Kavanaugh took no part in the court's action. Alito owns $15,000 to $50,000 in Johnson & Johnson stock. Kavanaugh's father headed the trade association that lobbied against labeling talc a carcinogen and including a warning label on talc products.
Ethicists contacted by The Associated Press said they did not think E. Edward Kavanaugh's role required his son to step aside from the case.
Serve Robotics CEO Ali Kashani discusses expanding beyond Uber, adding new delivery partners and scaling autonomous robots as delivery moves into the mainstream
Citrotech CEO Wes Bolsen discusses how innovative building materials could prevent fires, slow their spread and reshape the future of fire-safe construction.
Complex President Moksha Fitzgibbons explains how the brand is blending media, AI, e-commerce, sports & live experiences to build a new kind of culture business
Amazon’s Daniel Rausch, VP of Alexa and Echo, on Alexa’s AI evolution, the future of voice commerce and why your next shopping assistant could be Alexa.
